Friday, March 25, 2011
Short Course of Hormone Therapy Boosts Prostate Cancer Survival: Study (HealthDay)
Study
(HealthDay): "HealthDay - THURSDAY, March 24 (HealthDay News) -- Just six months of hormone
therapy, along with radiation, cuts the risk of dying from locally
advanced prostate cancer in half when compared to radiation alone,
researchers report."
Tuesday, March 15, 2011
Men's fertility may be regained sugically after cancer
(AP): "AP - New research shows a painstaking surgical technique can help some men deemed infertile because of childhood cancer treatment to become fathers after all."
Surgeons essentially perform tiny biopsies of testicular tissue to hunt any pockets of hidden sperm, which then are used in standard in vitro fertilization to attempt a partner's pregnancy.
In cancer survivors, they were able to extract small amounts of sperm from more than a third of the men — 27 of 73. Doctors then attempted injecting the sperm into a partner's eggs in hopes of pregnancy. The result: 20 children were born, including five pairs of twins, the researchers reported Monday in the Journal of Clinical Oncology.
Saturday, March 5, 2011
Key genital measurement linked to male fertility
Men whose AGD is shorter than the median length -- around 2 inches (52 mm) -- have seven times the chance of being sub-fertile as those with a longer AGD, according to a study published on Friday in the journal Environmental Health Perspectives.
That distance, measured from the anus to the underside of the scrotum, is linked to male fertility, including semen volume and sperm count, the study found. The shorter the AGD, the more likely a man was to have a low sperm count.
Thursday, March 3, 2011
Painkiller Use Related to Erection Problems
Researchers found that regular users of drugs like aspirin, acetaminophen, ibuprofen, and Celebrex were 38 percent more likely to have erectile dysfunction than men who didn't take the so-called nonsteroidal anti-inflammatory painkillers.
Such drugs are thought to block the hormones that govern men's erections.
After accounting for factors like age, weight, high blood pressure and heart disease, the researchers still found a 38-percent higher risk of erectile dysfunction among men on painkillers.
Still, because the study didn't test painkillers directly, Inman cautioned that men shouldn't stop using painkillers for fear that it would cut their chances of getting an erection.
Friday, February 25, 2011
PSA spikes are poor predictors of prostate cancer
If a man's PSA has risen rapidly in recent years, there is no cause for concern if his total PSA level is still low and his clinical exam is normal.
He said the large study adds to others showing that changes in PSA should not be used alone as a basis for getting a biopsy. Besides cancer, other conditions, including an enlarged prostate and infections, can cause PSA levels to rise.
Once diagnosed, more than 90 percent of men with low-grade prostate cancer get treated, most often with surgery or radiation. Both can cause lasting side effects including impotence or incontinence.
Wednesday, February 16, 2011
Drug may slow growth of early prostate cancer (AP)
(AP): "AP - A new study suggests a way to help men with early, low-risk prostate cancer avoid being overtreated for a disease that in most cases will never threaten their lives. It found that a drug can slow the growth of these tumors in men who opt to be monitored instead of having treatment right away."
This is the first time that a drug for treating enlarged prostates also has been shown to help treat prostate cancer in a rigorous study. It may persuade more men to choose active surveillance, or "watchful waiting," instead of rushing to have treatments that can leave them with urinary or sexual problems, doctors say.
However, the results also show that most of these men do very well with no treatment at all.
Doctors know that drugs that shrink the prostate — GlaxoSmithKline PLC's Avodart and Merck & Co.'s Proscar — can help prevent prostate cancer. But federal health advisers recently recommended against taking them for this purpose because of potential risks.
The new study tested Avodart "not to prevent cancer, but to prevent the progression" of it in men who already have the disease, which may be a much better use of such drugs, said the study's leader, Dr. Neil FleshnerDoctors don't think Avodart can cure cancers, but it seems to suppress it, said Dr. Howard Sandler, a prostate cancer specialist at Cedars-Sinai Medical Center in Los Angeles. He had no role in the study but is involved with the cancer conference.
Sandler said Avodart might relieve some men's anxiety about monitoring their disease and may make them more comfortable not having immediate treatment.
Early balding related to prostate cancer risk
If the men only started going bald when they were 30 or 40, there was no difference in their risk of developing prostate cancer compared to the healthy group.
At present there is no hard evidence to show any benefit from screening the general population for prostate cancer. We need a way of identifying those men who are at high risk.
Further work should be done, both at the molecular level and with larger groups of men, to find the missing link between androgens, early balding and prostate cancer.